Procter & Gamble Health Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Procter & Gamble Health Limited's yearly results (2022–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Debt due within a year is covered 94.6 times by its yearly operating cash. Higher than 96% of Healthcare companies in India.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 10.1 times. Higher than 95% of Healthcare companies in India.
- Growth Efficiency Ratio: Sales grew 27% in 3 years; of every extra ₹100 of sales, ₹46 became extra profit. Higher than 91% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹106Over the last 3 years, every ₹100 of reported profit came with ₹106 of operating cash.
Lower than 51% of Healthcare companies in India.
Self-Funding Ratio
10.1×Over the last 3 years its own operating cash covered its investment spending (capex) 10.1 times.
Higher than 95% of Healthcare companies in India.
Cash Locked Ratio
₹6For every ₹100 of sales, ₹6 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹1 from others' credit three years earlier.
Less money tied up than 79% of Healthcare companies in India.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Less steady than 68% of Healthcare companies in India.
Growth Efficiency Ratio
₹46Sales grew 27% in 3 years; of every extra ₹100 of sales, ₹46 became extra profit.
Higher than 91% of Healthcare companies in India.
Asset Productivity Ratio
+27% / -5%In 3 years sales changed by +27% while total assets changed by -5%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
94.6×Debt due within a year is covered 94.6 times by its yearly operating cash.
Higher than 96% of Healthcare companies in India.
Cash Cushion Ratio
+2%Cash, after subtracting all debt, equals 2% of its market value (net cash).
Higher than 69% of Healthcare companies in India.
Tangible Assets Ratio
100%Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 87% of Healthcare companies in India.
Tangible Net Worth Ratio
100%Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 87% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Procter & Gamble Health Limited owes ₹0.38 for every ₹1 it owns. Net profit rose 63% in the year to Mar 2026, and grew 19% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
23.3Investors pay ₹23.3 for every ₹1 of Procter & Gamble Health Limited's yearly profit, lower than 75% of Healthcare companies in India.
P/B ratio
15.87The share price is 15.87 times Procter & Gamble Health Limited's book value per share, higher than 95% of Healthcare companies in India.
Market cap
₹8,325 CrThe total market value of all of Procter & Gamble Health Limited's shares at today's price (share price × number of shares), larger than 61% of Healthcare companies in India. PosiCap size class: Mini Cap.
Net worth (book value)
₹525 CrWhat Procter & Gamble Health Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹316.01Net worth divided by the number of shares. The share price of ₹5,015 is 15.9 times this, which is the P/B above.
Return on equity (ROE)
68.1%Procter & Gamble Health Limited earned 68.1% on its shareholders' money over the last year, higher than almost all Healthcare companies in India.
Owes vs Owns
0.38×Procter & Gamble Health Limited owes ₹0.38 for every ₹1 it owns (low), higher than 51% of Healthcare companies in India.
Dividend yield
2.98%Procter & Gamble Health Limited pays 2.98% of its share price as dividends a year, higher than almost all dividend-paying Healthcare companies in India.
Revenue growth
+23%Revenue rose 23% in the year to Mar 2026, and grew 8% a year on average over 3 years.
Profit growth
+63%Net profit rose 63% in the year to Mar 2026, and grew 19% a year on average over 3 years.
Profit margin
23.6%Procter & Gamble Health Limited keeps ₹24 of every ₹100 of revenue as net profit.
Cash quality
1.03×Cash from Procter & Gamble Health Limited's business was 1.03× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
790.8×Procter & Gamble Health Limited's operating profit covered its interest costs 790.8 times in the year to Mar 2026.
Cash vs debt
Net cashProcter & Gamble Health Limited held ₹168 Cr more cash than debt (net cash) at Mar 2026.
Questions
What is Procter & Gamble Health Limited's P/E ratio?
Investors pay ₹23.3 for every ₹1 of Procter & Gamble Health Limited's yearly profit, lower than 75% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Procter & Gamble Health Limited: ₹8,325 Cr ÷ ₹525 Cr (31 Mar 2026) = 15.9.
What is Procter & Gamble Health Limited's return on equity?
Procter & Gamble Health Limited earned 68.1% on its shareholders' money over the last year, higher than almost all Healthcare companies in India.
How much does Procter & Gamble Health Limited owe compared with what it owns?
Procter & Gamble Health Limited owes ₹0.38 for every ₹1 it owns (low), higher than 51% of Healthcare companies in India.
Does Procter & Gamble Health Limited pay a dividend?
Yes. Procter & Gamble Health Limited pays 2.98% of its share price as dividends a year, higher than almost all dividend-paying Healthcare companies in India.
Is Procter & Gamble Health Limited's revenue growing?
Revenue rose 23% in the year to Mar 2026, and grew 8% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.